Concert Pharmaceuticals Highlights CTP-656 Phase 1 Results at North American Cystic Fibrosis Conference
October 08, 2015 at 14:53 PM EDT
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today presented results from a Phase 1 single ascending dose trial of ...
